170 related articles for article (PubMed ID: 8355147)
1. [Quenching of ethidium-DNA fluorescence by novel acridines with antitumor activities. II. The structure-activity relationship in acridines with fluorescence quenching of ethidium-DNA].
Kimura M; Inoue H; Uchitubo T; Kojima H; Okabayashi I
Yakugaku Zasshi; 1993 Jun; 113(6):454-9. PubMed ID: 8355147
[TBL] [Abstract][Full Text] [Related]
2. [Quenching of ethidium-DNA fluorescence by novel acridines with antitumor activities].
Kimura M
Yakugaku Zasshi; 1992 Dec; 112(12):914-8. PubMed ID: 1294716
[TBL] [Abstract][Full Text] [Related]
3. Antitumour polycyclic acridines. Part 4. Physico-chemical studies on the interactions between DNA and novel tetracyclic acridine derivatives.
Giménez-Arnau E; Missailidis S; Stevens MF
Anticancer Drug Des; 1998 Jul; 13(5):431-51. PubMed ID: 9702209
[TBL] [Abstract][Full Text] [Related]
4. Quenching of DNA-ethidium fluorescence by amsacrine and other antitumor agents: a possible electron-transfer effect.
Baguley BC; Le Bret M
Biochemistry; 1984 Feb; 23(5):937-43. PubMed ID: 6546881
[TBL] [Abstract][Full Text] [Related]
5. Potential antitumor agents. 34. Quantitative relationships between DNA binding and molecular structure for 9-anilinoacridines substituted in the anilino ring.
Baguley BC; Denny WA; Atwell GJ; Cain BF
J Med Chem; 1981 Feb; 24(2):170-7. PubMed ID: 7205885
[TBL] [Abstract][Full Text] [Related]
6. Electron donor properties of the antitumour drug amsacrine as studied by fluorescence quenching of DNA-bound ethidium.
Davis LM; Harvey JD; Baguley BC
Chem Biol Interact; 1987; 62(1):45-58. PubMed ID: 3581286
[TBL] [Abstract][Full Text] [Related]
7. Antitumour polycyclic acridines. Part 2. Physicochemical studies on the interactions between DNA and novel polycyclic acridine derivatives.
Giménez-Arnau E; Missailidis S; Stevens MF
Anticancer Drug Des; 1998 Mar; 13(2):125-43. PubMed ID: 9524555
[TBL] [Abstract][Full Text] [Related]
8. 9-substituted acridine derivatives with long half-life and potent antitumor activity: synthesis and structure-activity relationships.
Su TL; Chou TC; Kim JY; Huang JT; Ciszewska G; Ren WY; Otter GM; Sirotnak FM; Watanabe KA
J Med Chem; 1995 Aug; 38(17):3226-35. PubMed ID: 7650675
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antiproliferative activity of some variously substituted acridine and azacridine derivatives.
Ferlin MG; Marzano C; Chiarelotto G; Baccichetti F; Bordin F
Eur J Med Chem; 2000 Sep; 35(9):827-37. PubMed ID: 11006484
[TBL] [Abstract][Full Text] [Related]
10. DNA-binding antitumor agents: from pyrimido[5,6,1-de]acridines to other intriguing classes of acridine derivatives.
Antonini I
Curr Med Chem; 2002 Sep; 9(18):1701-16. PubMed ID: 12171552
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapeutic potential of 9-phenyl acridine: biophysical studies on its binding to DNA.
Ghosh R; Bhowmik S; Bagchi A; Das D; Ghosh S
Eur Biophys J; 2010 Jul; 39(8):1243-9. PubMed ID: 20135310
[TBL] [Abstract][Full Text] [Related]
12. DNA Bifunctional intercalators. 2. Fluorescence properties and DNA binding interaction of an ethidium homodimer and an acridine ethidium heterodimer.
Gaugain B; Barbet J; Capelle N; Roques BP; Le Pecq JB
Biochemistry; 1978 Nov; 17(24):5078-88. PubMed ID: 569495
[TBL] [Abstract][Full Text] [Related]
13. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome.
Vispé S; Vandenberghe I; Robin M; Annereau JP; Créancier L; Pique V; Galy JP; Kruczynski A; Barret JM; Bailly C
Biochem Pharmacol; 2007 Jun; 73(12):1863-72. PubMed ID: 17391647
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of RNA synthesis in vitro by acridines--relation between structure and activity.
Piestrzeniewicz MK; Wilmańska D; Studzian K; Szemraj J; Czyz M; Denny WA; Gniazdowski M
Z Naturforsch C J Biosci; 1998; 53(5-6):359-68. PubMed ID: 9679327
[TBL] [Abstract][Full Text] [Related]
15. A Review on Acridines as Antiproliferative Agents.
Baliwada A; Rajagopal K; Varakumar P; Raman K; Byran G
Mini Rev Med Chem; 2022; 22(21):2769-2798. PubMed ID: 35546777
[TBL] [Abstract][Full Text] [Related]
16. Novel synthetic acridine derivatives as potent DNA-binding and apoptosis-inducing antitumor agents.
Lang X; Li L; Chen Y; Sun Q; Wu Q; Liu F; Tan C; Liu H; Gao C; Jiang Y
Bioorg Med Chem; 2013 Jul; 21(14):4170-7. PubMed ID: 23735826
[TBL] [Abstract][Full Text] [Related]
17. Correlation between DNA/HSA-interactions and antimalarial activity of acridine derivatives: Proposing a possible mechanism of action.
de M Silva M; Macedo TS; Teixeira HMP; Moreira DRM; Soares MBP; da C Pereira AL; de L Serafim V; Mendonça-Júnior FJB; do Carmo A de Lima M; de Moura RO; da Silva-Júnior EF; de Araújo-Júnior JX; de A Dantas MD; de O O Nascimento E; Maciel TMS; de Aquino TM; Figueiredo IM; Santos JCC
J Photochem Photobiol B; 2018 Dec; 189():165-175. PubMed ID: 30366283
[TBL] [Abstract][Full Text] [Related]
18. The possible role of electron-transfer complexes in the antitumour action of amsacrine analogues.
Baguley BC
Biophys Chem; 1990 Apr; 35(2-3):203-12. PubMed ID: 2204443
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, structure-activity relationship and biological activity of acridine derivatives as potent MDR-reversing agents.
Wang J; Luo T; Li S; Zhhang Y; Wang C; Zhao J
Curr Med Chem; 2013; 20(32):4070-9. PubMed ID: 23895691
[TBL] [Abstract][Full Text] [Related]
20. [Topoisomerase II mediated DNA strand cleavage and antitumor activities against murine leukemia P388 of novel acridines].
Kimura M
Yakugaku Zasshi; 1994 May; 114(5):304-7. PubMed ID: 8014839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
